The promise of mTOR as a therapeutic target pathway in idiopathic pulmonary fibrosis

Manuela Platé, Delphine Guillotin, Rachel C Chambers

Source: Eur Respir Rev, 29 (157) 200269; 10.1183/16000617.0269-2020
Journal Issue: September
Disease area: Interstitial lung diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Manuela Platé, Delphine Guillotin, Rachel C Chambers. The promise of mTOR as a therapeutic target pathway in idiopathic pulmonary fibrosis. Eur Respir Rev, 29 (157) 200269; 10.1183/16000617.0269-2020

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: